ACE inhibitor lisinopril in cardiac patients: results of evidence-based trials

1. Furberg C.D. Are drags within a class interchangeable? Lancet 1999; 354: 1202-1204.

2. Furberg C.D., Pitt B. Are all angiotensin-converting enzyme inhibitors interchangeable? J. Amer. Coll. Cardiol. 2001; 37: 1456-1460.

3. Gruppo Italiano per lo Studio della Soprawivenza nell'Infarto Miocardico. GISSI-3: effects of lisinopril and transdermal glyceryl trinitrate singly and together on 6-week mortality and ventricular function after acute myocardial infarction. Lancet 1994; 343: 1115-1122.

4. Massie B.M., Armstrong P.W., Cleland J.G.F., et al. Toleration of high doses of angiotensin-converting enzyme inhibitors in patients with chronic heart failure. Arch. Intern. Med. 2001; 161: 165-171.

5. Simpson K., Jarvis В. Lisinopril. A review of its use in congestive heart failure. Drugs 2000; 59: 1149-1167.

6. Houston M., Asher J.R., Naftilan A.J. Hypertension Institute ALL-HAT clinical review: ALLHAT not all that it's cracked up to be: review of the facts and the science. J. Amer. Nutraceutic. Association 2003; 6: 1-4.

7. Недогода С.В., Марченко И.В., Чаляби Т.А. Сравнительная антитипертензивная эффективность генериков ангиотензинпревращающего фермента эналаприла (ренитека, энапа, эднита, инворила, энваса и энама) и стоимость лечения у больных гипертонической болезнью. Артериальная гипертензия 2000: 1: 52-55.